- Intellectual property investor IP Group said its portfolio company Oxford Nanopore Technologies had announced that it was in advanced development of an end-to-end test for the detection of the Covid-19 virus.

The 'LamPORE' an end-to-end test (assay), based on Oxford Nanopore's DNA/RNA sequencing technology, was designed to cater to on-demand analysis of smaller sample numbers, to very large numbers of samples, the company said.

IP Group held an a stake of 16.4% in Oxford Nanopore.

At 8:33am: [LON:IPO] Ip Group PLC share price was +1.1p at 59p

Story provided by